S. Jarmin, H. Kymalainen, L. Popplewell, and G. Dickson, New developments in the use of gene therapy to treat Duchenne muscular dystrophy, Expert Opin Biol Ther, vol.14, issue.2, pp.209-230, 2014.

N. J. Sharp, J. N. Kornegay, S. D. Van-camp, M. H. Herbstreith, and S. L. Secore, An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy, Genomics, vol.13, pp.115-121, 1992.

N. Klymiuk, A. Blutke, A. Graf, S. Krause, and K. Burkhardt, Dystrophindeficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle, Hum Mol Genet, vol.22, pp.4368-4382, 2013.

K. Hollinger, C. X. Yang, R. E. Montz, D. Nonneman, and J. W. Ross, Dystrophin insufficiency causes selective muscle histopathology and loss of dystrophin-glycoprotein complex assembly in pig skeletal muscle, FASEB J, vol.28, pp.1600-1609, 2014.

G. Bulfield, W. G. Siller, P. A. Wight, and K. J. Moore, X chromosome-linked muscular dystrophy (mdx) in the mouse, Proc Natl Acad Sci, vol.81, pp.1189-1192, 1984.

T. A. Partridge, The mdx mouse model as a surrogate for Duchenne muscular dystrophy, FEBS J, vol.280, pp.4177-4186, 2013.

A. Nakamura and S. Takeda, Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications, J Biomed Biotechnol, p.184393, 2011.

H. J. Jacob and A. E. Kwitek, rat genetics: attaching physiology and pharmacology to the genome, Nat Rev Genet, vol.3, pp.33-42, 2002.

S. Ménoret, S. Fontanière, D. Jantz, L. Tesson, and R. Thinard, Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases, FASEB J, vol.27, pp.703-711, 2013.

A. M. Geurts, G. J. Cost, Y. Freyvert, B. Zeitler, and J. C. Miller, Knockout rats via embryo microinjection of zinc-finger nucleases, Science, vol.325, p.433, 2009.

S. Remy, L. Tesson, S. Menoret, C. Usal, D. Cian et al., Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases, Genome Res, 2014.

L. Tesson, C. Usal, S. Ménoret, E. Leung, and B. J. Niles, Knockout rats generated by embryo microinjection of TALENs, Nat Biotechnol, vol.29, pp.695-696, 2011.

D. Li, Z. Qiu, Y. Shao, Y. Chen, and Y. Guan, Heritable gene targeting in the mouse and rat using a CRISPR-Cas system, Nat Biotechnol, vol.31, pp.681-683, 2013.

T. O. Auer, K. Duroure, A. De-cian, J. P. Concordet, D. Bene et al., Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair, Genome Res, vol.24, pp.142-153, 2014.

M. Piganeau, H. Ghezraoui, A. De-cian, L. Guittat, and M. Tomishima, Cancer translocations in human cells induced by zinc finger and TALE nucleases, Genome Res, vol.23, pp.1182-1193, 2013.

P. Huang, A. Xiao, M. Zhou, Z. Zhu, and S. Lin, Heritable gene targeting in zebrafish using customized TALENs, Nat Biotechnol, vol.29, pp.699-700, 2011.

J. C. Miller, S. Tan, G. Qiao, K. A. Barlow, and J. Wang, A TALE nuclease architecture for efficient genome editing, Nat Biotechnol, vol.29, pp.143-148, 2011.

Y. Doyon, T. D. Vo, M. C. Mendel, S. G. Greenberg, and J. Wang, Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures, Nat Methods, vol.8, pp.74-79, 2011.

E. J. Fine, T. J. Cradick, C. L. Zhao, Y. Lin, and G. Bao, An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage, Nucleic Acids, vol.42, p.42, 2014.

A. M. Geurts, G. J. Cost, S. Rémy, X. Cui, and L. Tesson, Generation of gene-specific mutated rats using zinc-finger nucleases, Methods Mol Biol, vol.597, pp.211-225, 2010.

R. J. Bartlett, S. Stockinger, M. M. Denis, W. T. Bartlett, and L. Inverardi, In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide, Nat Biotechnol, vol.18, pp.15-622, 2000.

V. Dubowitz and M. H. Brooke, Muscle Biopsy: a Modern Approach, pp.335-356, 1985.

M. Carre-pierrat, A. Lafoux, G. Tanniou, L. Chambonnier, and A. Divet, Pre-clinical study of 21 approved drugs in the mdx mouse, Neuromuscul Disord, vol.21, pp.313-327, 2011.

A. M. De-luca, Use of grip strength meter to assess the limb strength of mdx mice, 2008.

N. Kanneboyinna, Behavioural and Locomotor Measurements Using Open Field Animal Activity Monitoring System, 2008.

V. Arechavala-gomeza, M. Kinali, L. Feng, M. Guglieri, and G. Edge, Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials, Neuromuscul Disord, vol.20, pp.295-301, 2010.

J. Muller, N. Vayssiere, M. Royuela, M. E. Leger, and A. Muller, Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice, J Muscle Res Cell Motil, vol.22, pp.133-139, 2001.

S. Lin, F. Gaschen, and J. M. Burgunder, Utrophin is a regeneration-associated protein transiently present at the sarcolemma of regenerating skeletal muscle fibers in dystrophin-deficient hypertrophic feline muscular dystrophy, Neuropathol Exp Neurol, vol.57, pp.780-790, 1998.

I. Desguerre, C. Christov, M. Mayer, R. Zeller, and H. M. Becane, Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of subphenotypes and predictive criteria by long-term follow-up, PLoS One, vol.4, p.4347, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00447998

E. P. Hoffman, R. H. Brown, and L. M. Kunkel, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, vol.51, pp.919-928, 1987.

M. Koenig, A. P. Monaco, and L. M. Kunkel, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, vol.53, pp.219-228, 1988.

F. Muntoni, S. Torelli, and A. Ferlini, Dystrophin and mutations: one gene, several proteins, multiple phenotypes, Lancet Neurol, vol.12, pp.731-771, 2003.

K. J. Nowak and K. E. Davies, Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment, EMBO Rep, vol.5, pp.872-876, 2004.

W. Klingler, K. Jurkat-rott, F. Lehmann-horn, and R. Schleip, The role of fibrosis in Duchenne muscular dystrophy, Acta Myol, vol.31, pp.184-95, 2012.

N. P. Whitehead, E. W. Yeung, and D. G. Allen, Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species, Clin Exp Pharmacol Physiol, vol.33, pp.657-662, 2006.

D. G. Allen, O. L. Gervasio, E. W. Yeung, and N. P. Whitehead, Calcium and the damage pathways in muscular dystrophy, Can J Physiol Pharmacol, vol.88, pp.83-91, 2010.

P. Kieny, S. Chollet, P. Delalande, L. Fort, M. Magot et al., Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between, Ann Phys Rehabil Med, vol.56, pp.443-454, 1981.

K. Nakamura, W. Fujii, M. Tsuboi, J. Tanihata, and N. Teramoto, Generation of muscular dystrophy model rats with a CRISPR/Cas system, Sci Rep, vol.4, pp.5635-56, 2014.

A. Sacco, F. Mourkioti, R. Tran, J. Choi, and M. Llewellyn, Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice, Cell, vol.143, pp.1059-1071, 2010.

F. Mourkioti, J. Kustan, P. Kraft, J. W. Day, and M. M. Zhao, Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy, Nat Cell Biol, vol.15, pp.895-904, 2013.